Correction to: Comparative Effectiveness and Tolerability of the Pharmacology of Monoclonal Antibodies Targeting the Calcitonin Gene-Related Peptide and Its Receptor for the Prevention of Chronic Migraine: a Network Meta-analysis of Randomized Controlled Trials (Neurotherapeutics, (2021), 18, 4, (2639-2650), 10.1007/s13311-021-01128-0)

Chun Pai Yang, Bing Yan Zeng, Ching Mao Chang, Po Hsuan Shih, Cheng Chia Yang, Ping Tao Tseng, Shuu Jiun Wang*

*此作品的通信作者

研究成果: Comment/debate

摘要

The original version of this article was revised to add a second affiliation “Division of Endocrinology & Metabolism, Department of Internal Medicine, E-DA Dachang Hospital, Kaohsiung, Taiwan” to author Bing-Yan Zeng. The Original article has been corrected.

原文English
頁(從 - 到)2755
頁數1
期刊Neurotherapeutics
18
發行號4
DOIs
出版狀態E-pub ahead of print - 10月 2021

指紋

深入研究「Correction to: Comparative Effectiveness and Tolerability of the Pharmacology of Monoclonal Antibodies Targeting the Calcitonin Gene-Related Peptide and Its Receptor for the Prevention of Chronic Migraine: a Network Meta-analysis of Randomized Controlled Trials (Neurotherapeutics, (2021), 18, 4, (2639-2650), 10.1007/s13311-021-01128-0)」主題。共同形成了獨特的指紋。

引用此